Mirati Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mirati Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2022.
  • Mirati Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$172M, a 7.72% increase year-over-year.
  • Mirati Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$765M, a 2.68% decline year-over-year.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$760M, a 32.5% decline from 2021.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$573M, a 55.2% decline from 2020.
  • Mirati Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$369M, a 66.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$760M -$186M -32.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 -$573M -$204M -55.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$369M -$147M -66.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$222M -$119M -116% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$103M -$31.1M -43.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$71.5M +$12.2M +14.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$83.8M -$19.1M -29.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$64.7M -$25.6M -65.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$39.1M -$7.11M -22.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 -$32M -$11.5M -56.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 -$20.5M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.